The Mass-SIREN Group
Mass-SIRN 集团
基本信息
- 批准号:10197232
- 负责人:
- 金额:$ 16.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAdministrative CoordinationAreaBostonCardiologyCardiopulmonaryChildClinicalClinical ResearchClinical TrialsClinical Trials NetworkCollaborationsCommunity HospitalsDataDiseaseEmergency CareEmergency Department patientEmergency SituationEmergency researchEnrollmentEnsureFundingGeneral HospitalsHematologyHospitalsIndividualInfrastructureInternationalIsraelJointsLeadershipMassachusettsMedicalMedical centerMedical emergencyModelingNeurologicNeurologyNew EnglandOperative Surgical ProceduresPatient CarePatient RecruitmentsPatientsPediatric HospitalsPerformancePositioning AttributePre-hospital settingPre-hospitalization careProtocol ComplianceProtocols documentationProviderPublic HealthPublicationsPulmonologyRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResourcesRuralSpecialistTrainingTraumaTrauma ResearchUniversitiesWomanacute careclinical centerdesignexperienceflexibilityimprovedinnovationmedical specialtiesmembernovelpragmatic trialprovider networksrural settingsuburbtertiary careunderserved minority
项目摘要
This application will create a Network Clinical Center (Hub) for the Strategies to Innovate EmeRgENcy
Care Clinical Trials Network (SIREN). We propose an integrated, collaborative team of high volume tertiary
care medical centers with expertise in emergency care clinical research. The team includes an administrative
Hub at Massachusetts General Hospital (MGH) with Spokes across the state including Baystate Medical
Center, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston Medical Center, Brigham &
Women's Hospital, UMass Memorial Medical Center, and St. Vincent Hospital. The Mass-SIREN Group will be
managed by a Steering Committee including leaders from each of the member hospitals. It will function
administratively as a Hub and Spoke model, but operationally as a collaborative team of medical centers. Our
team also includes nationally- and internationally-recognized leaders in neurology, cardiology, pulmonology,
hematology, and trauma; we will propose novel ideas for the SIREN network, and innovative solutions to
common problems in clinical trials including enrollment and retention. Specific Aims include:
Aim 1: To establish an administrative Hub for the SIREN Clinical Trials Network at MGH. This Hub will
enroll in each clinical trial. Additionally it will provide administrative coordination across the entire team.
Aim 2. To establish the Mass-SIREN Steering Committee, an integrated leadership team that will
coordinate trial management and enrollment across all of our centers.
Aim 3. To provide our existing network of prehospital providers with the regulatory and educational
infrastructure to ensure that trained EMS teams can successfully participate in SIREN clinical trials.
Aim 4. To further establish the Mass-SIREN Steering Committee as innovative leaders in emergency
care research. We will leverage our individual areas of expertise, our local co-investigators, and our colleagues
with subspecialty expertise to design and propose innovative trials for the entire SIREN network.
Our academic centers have experience conducting clinical emergency care research, and all have
existing pools of trained clinical research coordinators that actively screen in the Emergency Department (ED)
to manage enrollment and protocol compliance. Our hospitals see a wide range of patients, including children,
underserved minorities, as well as those in urban, suburban, and rural settings. We include all major
prehospital providers in Boston and across Massachusetts. Finally, this application highlights our long history
of demonstrated interdisciplinary relationships, and that our team has a proven record of joint collaboration,
trial performance, and scientific publication.
Overall, the MASS-Siren Group includes both the breadth and depth of experience and resources to be
an outstanding Network Clinical Center for SIREN.
该应用程序将创建一个网络临床中心(HUB),以创新紧急策略
护理临床试验网络(Siren)。我们提出了一个大型第三级的综合合作团队
护理医疗中心具有急诊临床研究专业知识。团队包括一个行政
马萨诸塞州综合医院(MGH)的枢纽,全州辐条,包括Baystate Medical
中心,贝丝以色列女执事医疗中心,波士顿儿童医院,波士顿医疗中心,杨百翰&
妇女医院,UMASS纪念医疗中心和圣文森特医院。群众组将
由指导委员会管理,包括来自每个会员医院的领导人。它将起作用
在行政上是一个枢纽和讲话模型,但在运营上是医疗中心的协作团队。我们的
团队还包括国际和国际公认的神经病学,心脏病学,肺病学领导者,
血液学和创伤;我们将为警笛网络提出新颖的想法,以及创新的解决方案
临床试验中的常见问题,包括入学和保留。具体目的包括:
目标1:在MGH建立一个警笛临床试验网络的管理中心。这个枢纽会
参加每个临床试验。此外,它将在整个团队中提供行政协调。
目标2。建立大规模塞伦指导委员会,这是一个综合领导团队,将
协调我们所有中心的试用管理和注册。
目标3。为我们现有的院前提供商网络提供监管和教育
确保受过训练的EMS团队的基础设施可以成功参加Siren临床试验。
目的4。进一步建立大规模塞伦指导委员会作为紧急情况的创新领导者
护理研究。我们将利用我们的各个专业领域,当地的共同研究人员和我们的同事
凭借专业知识,可以为整个警笛网络设计和提出创新试验。
我们的学术中心有进行临床紧急护理研究的经验,并且都有
现有的训练有素的临床研究协调员池,这些协调员在急诊科积极筛查(ED)
管理注册和协议合规。我们的医院看到包括儿童在内的各种患者
服务不足的少数民族以及城市,郊区和农村环境中的少数民族。我们包括所有专业
波士顿和马萨诸塞州的院前提供商。最后,该应用程序突出了我们悠久的历史
有展示的跨学科关系,我们的团队具有共同合作的可靠记录,
试验性能和科学出版物。
总体而言,大众群体包括经验和资源的广度和深度
警笛的杰出网络临床中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua N Goldstein其他文献
Acute care bundles should be used for patients with intracerebral haemorrhage: An expert consensus statement
脑出血患者应使用急性护理集束:专家共识声明
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:6.1
- 作者:
A. Parry;Susann J. Järhult;N. Kreitzer;A. Morotti;Danilo S. Toni;D. Seiffge;A. D. Mendelow;Hiren Patel;H. Brouwers;C. Klijn;Thorsten Steiner;W.B. Gibler;Joshua N Goldstein - 通讯作者:
Joshua N Goldstein
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage.
脑出血后抗凝逆转的时间和结果。
- DOI:
10.1001/jamaneurol.2024.0221 - 发表时间:
2024 - 期刊:
- 影响因子:29
- 作者:
Kevin N. Sheth;Nicole Solomon;Brooke Alhanti;Steven R. Messé;Ying Xian;Deepak Bhatt;J. C. Hemphill;Jennifer A Frontera;Ray Chang;Ilya M Danelich;Joanna Huang;Lee H. Schwamm;Eric E Smith;Joshua N Goldstein;Brian C. Mac Grory;Gregg C Fonarow;Jeffrey Saver - 通讯作者:
Jeffrey Saver
Joshua N Goldstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua N Goldstein', 18)}}的其他基金
Predictors of hematoma expansion in acute intracerebral hemorrhage
急性脑出血血肿扩张的预测因子
- 批准号:
8423067 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
Predictors of hematoma expansion in acute intracerebral hemorrhage
急性脑出血血肿扩张的预测因素
- 批准号:
7660841 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
Predictors of hematoma expansion in acute intracerebral hemorrhage
急性脑出血血肿扩张的预测因素
- 批准号:
7777262 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
Predictors of hematoma expansion in acute intracerebral hemorrhage
急性脑出血血肿扩张的预测因子
- 批准号:
8220960 - 财政年份:2009
- 资助金额:
$ 16.76万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
- 批准号:
10687434 - 财政年份:2022
- 资助金额:
$ 16.76万 - 项目类别:
Characteristics of Transitions from Skilled Nursing Facility to Home Following Heart Failure Hospitalization
心力衰竭住院后从专业护理机构过渡到家庭的特点
- 批准号:
10711710 - 财政年份:2022
- 资助金额:
$ 16.76万 - 项目类别:
University of Washington Arboviral Research Network (UWARN)
华盛顿大学虫媒病毒研究网络 (UWARN)
- 批准号:
10493552 - 财政年份:2021
- 资助金额:
$ 16.76万 - 项目类别:
Optimizing Intensive Care Unit Staffing in the United States
优化美国重症监护病房的人员配置
- 批准号:
10611850 - 财政年份:2021
- 资助金额:
$ 16.76万 - 项目类别: